IL32 and cancer: VEGF expression was found to be correlated with the expression of IL-32 in cancers with invasion and migration ability such as lung, breast, and gastric cancers although it was indicated that IL-32γ pro angiogenetic activity was not mediated by VEGF (8, 10, 50).